
From 12–14 March 2026, the international sarcoma and rare cancercommunity gathered in Lugano for the ESMO Sarcoma and Rare CancersCongress 2026, one of the leading scientific meetings dedicated to theseoften under-represented tumour types.
The collaboration between EURACAN and ESMO continues to play a key role instrengthening the European ecosystem for rare cancer care and research. Thecongress provides a valuable platform for EURACAN clinicians and researchers toengage with the broader oncology community and exchange expertise withcolleagues from across Europe and beyond.
Events such as the ESMO Sarcoma and Rare Cancers Congress underline theimportance of collaboration across networks, institutions, and disciplines. ForEURACAN, participation in this congress reinforces its mission to strengthencooperation among specialised centres, accelerate research progress, andsupport the development of evidence-based guidelines for rare cancers.